Novozymes 2016 Full Year Results Conference Call

Novozymes reported full year 2016 results with 2% organic growth and record EBIT margins, supported by a strong pipeline of market-expanding opportunities. The company launched 8 new products in 2016 and targets 2-5% organic growth in 2017, with focus on emerging markets and high-growth segments like Hygiene and BioAg. Long-term impact targets remain unchanged with ROIC inclusion of goodwill at ≥26% and EBIT margin at ≥25%.